Medical Device News Magazine

Intellihealth Launches Evolve Mobile 3.0

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Intellihealth, a leading health-tech software and clinical services company that delivers a comprehensive and clinically proven medical model for treating obesity, has introduced version 3.0 of Evolve Mobile, the patient-side mobile app companion to the Evolve software-as-a-service platform for healthcare providers.

Intellihealth’s EvolveTM is a turnkey medical obesity treatment solution that easily integrates into any practice and streamlines all aspects of care, including assessment, diagnosis, prescription and treatment. Patients’ individualized treatment plans — addressing diet, behavior and psychology, as well as pharmacotherapy when appropriate — are developed and continually refined by expert obesity clinicians based on factors such as their medical history and health risks, electronic health record information, data from wearables and connected devices, and learning center progress.

Evolve Mobile 3.0 includes two significant new features: medication monitoring, which enables patients to set up personalized reminders to take their anti-obesity medications regularly and allows both patients and providers to monitor patterns to make sure prescriptions are being followed; and Apple Health and Google Fit integration, which supports seamless access to weight, blood pressure and heart-rate data from connected devices. Together, these tools offer patients and providers a more comprehensive view of overall health and program compliance over time. The upgrade also incorporates a range of performance improvements and updates throughout the app.

“Remote medication monitoring can improve the efficacy of treatment for many chronic diseases, and obesity is no exception,” said Venky Surya, CPTO at Intellihealth. “With Evolve Mobile 3.0, care teams can better monitor their patients’ medication usage as well as a variety of critical indicators, allowing them to closely track patients’ overall health and weight-loss progress and respond quickly when individualized treatment plans need to be adjusted. This reinforces positive messaging and leads to better patient engagement in our programs.”

The new features extend the app’s existing capabilities, which include meal planning tailored to individual dietary preferences; easy food, weight and activity logging; regular virtual visits and messaging with care team members; and educational resources and other tools to support engagement.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”